Skip to main content
OpenTrials

Clinical trial condition

Blood-Borne Infections

Explore clinical trials studying Blood-Borne Infections. Study availability and eligibility vary by location and protocol.

8,276 public trials 443 recruiting studies
Refine in advanced search Browse all conditions

Blood-Borne Infections trial results

Completed

Growth Hormone and/or Rosiglitazone for HIV-Associated Increased Abdominal Fat and Insulin Resistance

NCT00130286

Conditions
Blood-Borne Infections, Body Weight, Body Weight Changes, +28 more
Locations
  • AIDS Community Research Initiative of America (ACRIA) New York, United States
  • Cornell HIV Clinical Trials Unit, Weill Medical College of Cornell University New York, United States
  • St. Luke's-Roosevelt Hospital Center New York, United States
  • Columbia University College of Physicians and Surgeons New York, United States
View Trial Details
Completed

Early Versus Delayed Pneumococcal Vaccination in HIV

NCT00137605

Conditions
Bacterial Infections, Bacterial Infections and Mycoses, Blood-Borne Infections, +16 more
Locations
  • Medical Arts Health Research Group Kelowna, British Columbia, Canada
  • Downtown IDC Vancouver, British Columbia, Canada
  • St. Paul's Hospital Vancouver, British Columbia, Canada
  • St. Boniface General Hospital Winnipeg, Manitoba, Canada
View all 14 locations
View Trial Details
Completed

Virological Response Study of the HCV Vaccine IC41

NCT00601770

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Prof. Dr. Ulrich Spengler Bonn, Germany
  • Prof. Dr. Michael Manns Hanover, Hannover, Germany
  • Dr. Granzyna Cholewinska-Szymanska Warzawa, Poland
  • Prof. Dr. Andrzej Gladszy Wroclaw, Poland
View Trial Details
Completed

Oral Antivirals (GS-5885, Tegobuvir, and/or GS-9451) With Peginterferon Alfa 2a and Ribavirin in Treatment Experienced Subjects With Chronic Genotype 1 Hepatitis C Virus Infection

NCT01371578

Conditions
Blood-Borne Infections, Chronic Disease, Communicable Diseases, +14 more
Locations
  • Digestive Health Specialists of the Southeast Dothan, Alabama, United States
  • Alabama Liver and Digestive Specialists Montgomery, Alabama, United States
  • California Liver Institute Beverly Hills, California, United States
  • Scripps Clinic La Jolla, California, United States
View all 55 locations
View Trial Details
Completed

A Study to Investigate the Safety, Tolerability and Pharmacokinetics of Repeat Dose Administration of Long-Acting GSK1265744 and Long-Acting TMC278 Intramuscular and Subcutaneous Injections in Healthy Adult Subjects

NCT01593046

Conditions
Acquired Immunodeficiency Syndrome, Blood-Borne Infections, Communicable Diseases, +14 more
Locations
  • GSK Investigational Site Daytona Beach, Florida, United States
  • GSK Investigational Site Overland Park, Kansas, United States
View Trial Details
Completed

Study of Nitazoxanide, Peginterferon Alfa-2a and Ribavirin in Treatment-Naive Hepatitis C Patients

NCT00637923

Conditions
Blood-Borne Infections, Chronic Disease, Chronic Hepatitis C, +15 more
Locations
  • Palo Alto VA Healthcare System Palo Alto, California, United States
  • Yale University School of Medicine New Haven, Connecticut, United States
  • Bay Pines VA Healthcare System Bay Pines, Florida, United States
  • Florida Center for Gastroenterology Largo, Florida, United States
View Trial Details
Completed

Safety Study of Regimens of Sofosbuvir, GS-0938, and Ribavirin in Patients With Chronic Hepatitis C Infection

NCT01435044

Conditions
Blood-Borne Infections, Bronchial Diseases, Bronchiolitis, +25 more
Locations
  • Alabama Liver & Digestive Specialists Montgomery, Alabama, United States
  • Bakersfield, California, United States
  • Coronado, California, United States
  • La Mesa, California, United States
View all 44 locations
View Trial Details

Related conditions